Abstract |
Regulatory T cells can suppress activated CD4+ and CD8+ T effector cells and may serve as an impediment to spontaneous or therapeutic type 1 antitumor immunity. In a previous study, we observed minimal therapeutic impact, but significantly enhanced T cell cross-priming and lesional infiltration of tumor-reactive CD8+ T cells into established CMS4 sarcomas after combined treatment of BALB/c mice with rFLt3 ligand (rFL) and recombinant GM-CSF (rGM-CSF). In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively. Intracellular staining for Foxp3 protein revealed that combined treatment with rFL plus rGM-CSF results in a significant increase in CD4+Foxp3+ T cells in the spleen of both control and tumor-bearing mice, and that nearly half of CD4+ TIL expressed this marker. In addition, CD4+ TIL cells were of an activated/memory (ICOS(high)CD62L(low)CD45RB(low)) phenotype and were capable of suppressing allospecific T cell proliferation and IFN-gamma production from (in vivo cross-primed) anti-CMS4 CD8+ T cells in vitro, via a mechanism at least partially dependent on IL-10 and TGF-beta. Importantly, in vivo depletion of CD4+ T cells resulted in the ability of previously ineffective, rFL plus rGM-CSF therapy-induced CD8+ T cells to now mediate tumor regression.
|
Authors | Aklile Berhanu, Jian Huang, Simon C Watkins, Hideho Okada, Walter J Storkus |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 178
Issue 6
Pg. 3400-8
(Mar 15 2007)
ISSN: 0022-1767 [Print] United States |
PMID | 17339434
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antigens, CD
- Antigens, Differentiation, T-Lymphocyte
- Cytokines
- Forkhead Transcription Factors
- Foxp3 protein, mouse
- Glucocorticoid-Induced TNFR-Related Protein
- Icos protein, mouse
- Inducible T-Cell Co-Stimulator Protein
- Membrane Proteins
- flt3 ligand protein
|
Topics |
- Animals
- Antigens, CD
(immunology)
- Antigens, Differentiation, T-Lymphocyte
(immunology)
- CD8-Positive T-Lymphocytes
(immunology, pathology)
- Cell Line, Tumor
- Cell Proliferation
- Cytokines
(immunology, therapeutic use)
- Forkhead Transcription Factors
(immunology)
- Glucocorticoid-Induced TNFR-Related Protein
(immunology)
- Immunologic Memory
(drug effects)
- Immunotherapy
- Inducible T-Cell Co-Stimulator Protein
- Lymphocyte Activation
(immunology)
- Lymphocytes, Tumor-Infiltrating
(immunology, pathology)
- Membrane Proteins
(immunology, therapeutic use)
- Mice
- Mice, Inbred BALB C
- Neoplasms, Experimental
(immunology, pathology, therapy)
- Signal Transduction
(immunology)
- T-Lymphocytes, Regulatory
|